The United Nations Health Agency, the World Health Organization (WHO) has uncovered the association is breaking down dexamethasone, a steroid that researchers from the United Kingdom (UK) state can spare the lives of fundamentally sick COVID-19 patients.
Researchers from the University of Oxford, UK, reported on Tuesday that they had discovered dexamethasone relieved patients basically sick with Coronavirus.
Responding to the most recent disclosure, WHO Director-General, Dr. Tedros Adhanom Ghebreyesus says an inside and out examination of the medication will be completed before giving clinical direction on how and when the medication ought to be utilized.
Dr Tedros in a statement on Wednesday said;
“This is a welcome news. I congratulate the Government of the United Kingdom, University of Oxford, the research groups, hospitals, patients and families who have collectively contributed to this lifesaving breakthrough.
“WHO looks forward to learning more about the dexamethasone study. This is the first treatment to be shown to reduce mortality in severely ill patients with COVID-19 requiring oxygen or ventilator support.
“There are many ongoing clinical trials for COVID-19, including the Solidarity Trial launched by WHO and partners. It is hoped that more treatments under clinical evaluation will result in improving patient outcomes and save lives.
“While we are searching for COVID-19 treatments, we must continue strong efforts to prevent as many infections as possible by finding, isolating, testing and caring for every case; and tracing and quarantining every contact.”